GENTAUR Molecular Products.
Monoclonal Antibody, ELISA Kit, Polyclonal Antibody, Recombinant/Purified Protein.Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery
Histone-lysine N-methyltransferase SETD7 (EC 2.1.1.43) (Histone H3-K4 methyltransferase SETD7) (H3-K4-HMTase SETD7) (Lysine N-methyltransferase 7) (SET domain-containing protein 7) (SET7/9)
SETD7_HUMAN Reviewed; 366 AA.
Q8WTS6; B5WWL3; Q0VAH3; Q4W5A9; Q9C0E6;
15-NOV-2002, integrated into UniProtKB/Swiss-Prot.
01-MAR-2002, sequence version 1.
28-MAR-2018, entry version 161.
RecName: Full=Histone-lysine N-methyltransferase SETD7;
EC=2.1.1.43;
AltName: Full=Histone H3-K4 methyltransferase SETD7;
Short=H3-K4-HMTase SETD7;
AltName: Full=Lysine N-methyltransferase 7;
AltName: Full=SET domain-containing protein 7;
AltName: Full=SET7/9;
Name=SETD7; Synonyms=KIAA1717, KMT7, SET7, SET9;
Homo sapiens (Human).
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
Catarrhini; Hominidae; Homo.
NCBI_TaxID=9606;
[1]
NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 35-44; 108-115;
144-152; 234-258 AND 345-358, AND MUTAGENESIS OF HIS-297.
TISSUE=Brain;
PubMed=11779497; DOI=10.1016/S1097-2765(01)00405-1;
Wang H., Cao R., Xia L., Erdjument-Bromage H., Borchers C., Tempst P.,
Zhang Y.;
"Purification and functional characterization of a histone H3-lysine
4-specific methyltransferase.";
Mol. Cell 8:1207-1217(2001).
[2]
NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 36-45; 104-115;
144-152; 159-169; 201-250 AND 324-358, AND MUTAGENESIS OF HIS-297.
TISSUE=Cervix carcinoma;
PubMed=11850410; DOI=10.1101/gad.967202;
Nishioka K., Chuikov S., Sarma K., Erdjument-Bromage H., Allis C.D.,
Tempst P., Reinberg D.;
"Set9, a novel histone H3 methyltransferase that facilitates
transcription by precluding histone tail modifications required for
heterochromatin formation.";
Genes Dev. 16:479-489(2002).
[3]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
PubMed=15815621; DOI=10.1038/nature03466;
Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
Waterston R.H., Wilson R.K.;
"Generation and annotation of the DNA sequences of human chromosomes 2
and 4.";
Nature 434:724-731(2005).
[4]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
TISSUE=Brain;
PubMed=11214970; DOI=10.1093/dnares/7.6.347;
Nagase T., Kikuno R., Hattori A., Kondo Y., Okumura K., Ohara O.;
"Prediction of the coding sequences of unidentified human genes. XIX.
The complete sequences of 100 new cDNA clones from brain which code
for large proteins in vitro.";
DNA Res. 7:347-355(2000).
[5]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
PubMed=15489334; DOI=10.1101/gr.2596504;
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA
project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
[6]
FUNCTION.
PubMed=12588998; DOI=10.1128/MCB.23.5.1808-1816.2003;
Martens J.H., Verlaan M., Kalkhoven E., Zantema A.;
"Cascade of distinct histone modifications during collagenase gene
activation.";
Mol. Cell. Biol. 23:1808-1816(2003).
[7]
FUNCTION, AND MUTAGENESIS OF HIS-297.
PubMed=15099517; DOI=10.1016/S1097-2765(04)00182-0;
Kouskouti A., Scheer E., Staub A., Tora L., Talianidis I.;
"Gene-specific modulation of TAF10 function by SET9-mediated
methylation.";
Mol. Cell 14:175-182(2004).
[8]
FUNCTION, INTERACTION WITH IPF1, AND MUTAGENESIS OF HIS-297.
PubMed=16141209; DOI=10.1074/jbc.M505741200;
Francis J., Chakrabarti S.K., Garmey J.C., Mirmira R.G.;
"Pdx-1 links histone H3-Lys-4 methylation to RNA polymerase II
elongation during activation of insulin transcription.";
J. Biol. Chem. 280:36244-36253(2005).
[9]
FUNCTION.
PubMed=17108971; DOI=10.1038/nature05287;
Huang J., Perez-Burgos L., Placek B.J., Sengupta R., Richter M.,
Dorsey J.A., Kubicek S., Opravil S., Jenuwein T., Berger S.L.;
"Repression of p53 activity by Smyd2-mediated methylation.";
Nature 444:629-632(2006).
[10]
MUTAGENESIS OF GLU-220; GLU-228; TYR-245 AND LYS-294.
PubMed=16433545; DOI=10.1021/ja056153+;
Hu P., Zhang Y.;
"Catalytic mechanism and product specificity of the histone lysine
methyltransferase SET7/9: an ab initio QM/MM-FE study with multiple
initial structures.";
J. Am. Chem. Soc. 128:1272-1278(2006).
[11]
IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
PubMed=21269460; DOI=10.1186/1752-0509-5-17;
Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
"Initial characterization of the human central proteome.";
BMC Syst. Biol. 5:17-17(2011).
[12]
IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
TISSUE=Liver;
PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
Wang L., Ye M., Zou H.;
"An enzyme assisted RP-RPLC approach for in-depth analysis of human
liver phosphoproteome.";
J. Proteomics 96:253-262(2014).
[13]
X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 52-344.
PubMed=12372304; DOI=10.1016/S0092-8674(02)00964-9;
Wilson J., Jing C., Walker P., Martin S., Howell S., Blackburn G.,
Gamblin S., Xiao B.;
"Crystal structure and functional analysis of the histone
methyltransferase SET7/9.";
Cell 111:105-115(2002).
[14]
X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS).
PubMed=12389038; DOI=10.1038/nsb861;
Jacobs S.A., Harp J.M., Devarakonda S., Kim Y., Rastinejad F.,
Khorasanizadeh S.;
"The active site of the SET domain is constructed on a knot.";
Nat. Struct. Biol. 9:833-838(2002).
[15]
X-RAY CRYSTALLOGRAPHY (1.75 ANGSTROMS) OF 108-366 IN COMPLEX WITH
S-ADENOSYL-L-METHIONINE AND HISTONE PEPTIDE, FUNCTION, AND MUTAGENESIS
OF TYR-245.
PubMed=12540855; DOI=10.1038/nature01378;
Xiao B., Jing C., Wilson J.R., Walker P.A., Vasisht N., Kelly G.,
Howell S., Taylor I.A., Blackburn G.M., Gamblin S.J.;
"Structure and catalytic mechanism of the human histone
methyltransferase SET7/9.";
Nature 421:652-656(2003).
[16]
X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 70-366 IN COMPLEX WITH
S-ADENOSYL-L-METHIONINE.
PubMed=12514135; DOI=10.1093/emboj/cdg025;
Kwon T., Chang J.H., Kwak E., Lee C.W., Joachimiak A., Kim Y.C.,
Lee J., Cho Y.;
"Mechanism of histone lysine methyl transfer revealed by the structure
of SET7/9-AdoMet.";
EMBO J. 22:292-303(2003).
[17]
X-RAY CRYSTALLOGRAPHY (1.75 ANGSTROMS) OF 108-366, FUNCTION, AND
MUTAGENESIS OF HIS-297.
PubMed=15525938; DOI=10.1038/nature03117;
Chuikov S., Kurash J.K., Wilson J.R., Xiao B., Justin N., Ivanov G.S.,
McKinney K., Tempst P., Prives C., Gamblin S.J., Barlev N.A.,
Reinberg D.;
"Regulation of p53 activity through lysine methylation.";
Nature 432:353-360(2004).
[18]
X-RAY CRYSTALLOGRAPHY (1.3 ANGSTROMS) OF 110-366, BIOPHYSICOCHEMICAL
PROPERTIES, AND MUTAGENESIS OF LYS-317.
PubMed=16415881; DOI=10.1038/nsmb1045;
Couture J.-F., Collazo E., Hauk G., Trievel R.C.;
"Structural basis for the methylation site specificity of SET7/9.";
Nat. Struct. Mol. Biol. 13:140-146(2006).
-!- FUNCTION: Histone methyltransferase that specifically
monomethylates 'Lys-4' of histone H3. H3 'Lys-4' methylation
represents a specific tag for epigenetic transcriptional
activation. Plays a central role in the transcriptional activation
of genes such as collagenase or insulin. Recruited by IPF1/PDX-1
to the insulin promoter, leading to activate transcription. Has
also methyltransferase activity toward non-histone proteins such
as p53/TP53, TAF10, and possibly TAF7 by recognizing and binding
the [KR]-[STA]-K in substrate proteins. Monomethylates 'Lys-189'
of TAF10, leading to increase the affinity of TAF10 for RNA
polymerase II. Monomethylates 'Lys-372' of p53/TP53, stabilizing
p53/TP53 and increasing p53/TP53-mediated transcriptional
activation. {ECO:0000269|PubMed:12540855,
ECO:0000269|PubMed:12588998, ECO:0000269|PubMed:15099517,
ECO:0000269|PubMed:15525938, ECO:0000269|PubMed:16141209,
ECO:0000269|PubMed:17108971}.
-!- CATALYTIC ACTIVITY: S-adenosyl-L-methionine + L-lysine-[histone] =
S-adenosyl-L-homocysteine + N(6)-methyl-L-lysine-[histone].
{ECO:0000255|PROSITE-ProRule:PRU00910}.
-!- BIOPHYSICOCHEMICAL PROPERTIES:
Kinetic parameters:
KM=29 uM for histone H3 {ECO:0000269|PubMed:16415881};
KM=12 uM for TAF10 {ECO:0000269|PubMed:16415881};
KM=69 uM for p53/TP53 {ECO:0000269|PubMed:16415881};
-!- SUBUNIT: Interacts with IPF1/PDX-1. {ECO:0000269|PubMed:12514135,
ECO:0000269|PubMed:12540855, ECO:0000269|PubMed:16141209}.
-!- INTERACTION:
P26358:DNMT1; NbExp=9; IntAct=EBI-1268586, EBI-719459;
Q9WVH4:Foxo3 (xeno); NbExp=5; IntAct=EBI-1268586, EBI-6127038;
P68431:HIST1H3D; NbExp=3; IntAct=EBI-1268586, EBI-79722;
P68433:Hist1h3i (xeno); NbExp=2; IntAct=EBI-1268586, EBI-79743;
Q96RI1:NR1H4; NbExp=5; IntAct=EBI-1268586, EBI-1250177;
P06400:RB1; NbExp=4; IntAct=EBI-1268586, EBI-491274;
Q04206:RELA; NbExp=12; IntAct=EBI-1268586, EBI-73886;
Q04207:Rela (xeno); NbExp=2; IntAct=EBI-1268586, EBI-644400;
Q9UHV2:SERTAD1; NbExp=2; IntAct=EBI-1268586, EBI-748601;
Q96EB6:SIRT1; NbExp=11; IntAct=EBI-1268586, EBI-1802965;
Q12962:TAF10; NbExp=4; IntAct=EBI-1268586, EBI-708376;
P04637:TP53; NbExp=11; IntAct=EBI-1268586, EBI-366083;
-!- SUBCELLULAR LOCATION: Nucleus. Chromosome {ECO:0000305}.
-!- TISSUE SPECIFICITY: Widely expressed. Expressed in pancreatic
islets.
-!- DOMAIN: The SET domain is necessary but not sufficient for histone
methyltransferase activity.
-!- MISCELLANEOUS: Monomethyltransferase activity is achieved by
disrupting the formation at near-attack conformations for the
dimethylation reaction.
-!- SIMILARITY: Belongs to the class V-like SAM-binding
methyltransferase superfamily. Histone-lysine methyltransferase
family. SET7 subfamily. {ECO:0000255|PROSITE-ProRule:PRU00910}.
-!- SEQUENCE CAUTION:
Sequence=BAB21808.1; Type=Erroneous initiation; Evidence={ECO:0000305};
-----------------------------------------------------------------------
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
-----------------------------------------------------------------------
EMBL; AF448510; AAL56579.1; -; mRNA.
EMBL; AF462150; AAL69901.1; -; mRNA.
EMBL; AB051504; BAB21808.1; ALT_INIT; mRNA.
EMBL; AC112236; -; NOT_ANNOTATED_CDS; Genomic_DNA.
EMBL; AC114743; AAY40937.1; -; Genomic_DNA.
EMBL; BC121055; AAI21056.1; -; mRNA.
EMBL; BC121056; AAI21057.1; -; mRNA.
CCDS; CCDS3748.1; -.
RefSeq; NP_001293128.1; NM_001306199.1.
RefSeq; NP_085151.1; NM_030648.3.
UniGene; Hs.480792; -.
PDB; 1H3I; X-ray; 2.10 A; A/B=52-344.
PDB; 1MT6; X-ray; 2.20 A; A=58-337.
PDB; 1MUF; X-ray; 2.26 A; A=81-337.
PDB; 1N6A; X-ray; 1.70 A; A=108-366.
PDB; 1N6C; X-ray; 2.30 A; A=70-366.
PDB; 1O9S; X-ray; 1.75 A; A/B=108-366.
PDB; 1XQH; X-ray; 1.75 A; A/E=108-366.
PDB; 2F69; X-ray; 1.30 A; A=110-366.
PDB; 3CBM; X-ray; 1.69 A; A=111-366.
PDB; 3CBO; X-ray; 1.65 A; A=111-366.
PDB; 3CBP; X-ray; 1.42 A; A=111-366.
PDB; 3M53; X-ray; 1.85 A; A=110-366.
PDB; 3M54; X-ray; 1.60 A; A=110-366.
PDB; 3M55; X-ray; 1.55 A; A=110-366.
PDB; 3M56; X-ray; 1.65 A; A=110-366.
PDB; 3M57; X-ray; 1.70 A; A=110-366.
PDB; 3M58; X-ray; 1.40 A; A=110-366.
PDB; 3M59; X-ray; 1.70 A; A=110-366.
PDB; 3M5A; X-ray; 1.75 A; A=110-366.
PDB; 3OS5; X-ray; 1.69 A; A=111-366.
PDB; 3VUZ; X-ray; 2.50 A; A=111-366.
PDB; 3VV0; X-ray; 2.00 A; A=111-366.
PDB; 4E47; X-ray; 2.00 A; A/B/C/D=109-366.
PDB; 4J7F; X-ray; 1.59 A; A=110-366.
PDB; 4J7I; X-ray; 2.56 A; A=110-366.
PDB; 4J83; X-ray; 1.70 A; A=110-366.
PDB; 4J8O; X-ray; 1.63 A; A=110-366.
PDB; 4JDS; X-ray; 1.70 A; A/B/C/D=109-366.
PDB; 4JLG; X-ray; 1.90 A; A/B=109-366.
PDB; 5AYF; X-ray; 2.00 A; A=111-366.
PDB; 5EG2; X-ray; 1.55 A; A=110-366.
PDBsum; 1H3I; -.
PDBsum; 1MT6; -.
PDBsum; 1MUF; -.
PDBsum; 1N6A; -.
PDBsum; 1N6C; -.
PDBsum; 1O9S; -.
PDBsum; 1XQH; -.
PDBsum; 2F69; -.
PDBsum; 3CBM; -.
PDBsum; 3CBO; -.
PDBsum; 3CBP; -.
PDBsum; 3M53; -.
PDBsum; 3M54; -.
PDBsum; 3M55; -.
PDBsum; 3M56; -.
PDBsum; 3M57; -.
PDBsum; 3M58; -.
PDBsum; 3M59; -.
PDBsum; 3M5A; -.
PDBsum; 3OS5; -.
PDBsum; 3VUZ; -.
PDBsum; 3VV0; -.
PDBsum; 4E47; -.
PDBsum; 4J7F; -.
PDBsum; 4J7I; -.
PDBsum; 4J83; -.
PDBsum; 4J8O; -.
PDBsum; 4JDS; -.
PDBsum; 4JLG; -.
PDBsum; 5AYF; -.
PDBsum; 5EG2; -.
ProteinModelPortal; Q8WTS6; -.
SMR; Q8WTS6; -.
BioGrid; 123332; 45.
CORUM; Q8WTS6; -.
DIP; DIP-29045N; -.
IntAct; Q8WTS6; 21.
MINT; Q8WTS6; -.
STRING; 9606.ENSP00000274031; -.
BindingDB; Q8WTS6; -.
ChEMBL; CHEMBL5523; -.
DrugBank; DB01752; S-Adenosyl-L-Homocysteine.
GuidetoPHARMACOLOGY; 2703; -.
iPTMnet; Q8WTS6; -.
PhosphoSitePlus; Q8WTS6; -.
BioMuta; SETD7; -.
DMDM; 25091217; -.
EPD; Q8WTS6; -.
MaxQB; Q8WTS6; -.
PaxDb; Q8WTS6; -.
PeptideAtlas; Q8WTS6; -.
PRIDE; Q8WTS6; -.
Ensembl; ENST00000274031; ENSP00000274031; ENSG00000145391.
GeneID; 80854; -.
KEGG; hsa:80854; -.
UCSC; uc003ihw.4; human.
CTD; 80854; -.
DisGeNET; 80854; -.
EuPathDB; HostDB:ENSG00000145391.13; -.
GeneCards; SETD7; -.
HGNC; HGNC:30412; SETD7.
HPA; HPA058111; -.
MIM; 606594; gene.
neXtProt; NX_Q8WTS6; -.
OpenTargets; ENSG00000145391; -.
PharmGKB; PA143485615; -.
eggNOG; KOG1079; Eukaryota.
eggNOG; COG2940; LUCA.
GeneTree; ENSGT00390000004827; -.
HOGENOM; HOG000074731; -.
HOVERGEN; HBG028309; -.
InParanoid; Q8WTS6; -.
KO; K11431; -.
OMA; GSSVYHF; -.
OrthoDB; EOG091G08JN; -.
PhylomeDB; Q8WTS6; -.
TreeFam; TF106392; -.
BRENDA; 2.1.1.43; 2681.
Reactome; R-HSA-3214841; PKMTs methylate histone lysines.
ChiTaRS; SETD7; human.
EvolutionaryTrace; Q8WTS6; -.
GeneWiki; SETD7; -.
GenomeRNAi; 80854; -.
PRO; PR:Q8WTS6; -.
Proteomes; UP000005640; Chromosome 4.
Bgee; ENSG00000145391; -.
CleanEx; HS_SETD7; -.
ExpressionAtlas; Q8WTS6; baseline and differential.
Genevisible; Q8WTS6; HS.
GO; GO:0005694; C:chromosome; IEA:UniProtKB-SubCell.
GO; GO:0005730; C:nucleolus; IDA:HPA.
GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
GO; GO:0003682; F:chromatin binding; IEA:Ensembl.
GO; GO:0018024; F:histone-lysine N-methyltransferase activity; IDA:UniProtKB.
GO; GO:0002039; F:p53 binding; IPI:UniProtKB.
GO; GO:0016279; F:protein-lysine N-methyltransferase activity; IDA:UniProtKB.
GO; GO:0006974; P:cellular response to DNA damage stimulus; IDA:MGI.
GO; GO:0006325; P:chromatin organization; NAS:UniProtKB.
GO; GO:0070828; P:heterochromatin organization; IDA:MGI.
GO; GO:0018027; P:peptidyl-lysine dimethylation; IDA:UniProtKB.
GO; GO:0018026; P:peptidyl-lysine monomethylation; IDA:UniProtKB.
GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IEA:Ensembl.
GO; GO:0051570; P:regulation of histone H3-K9 methylation; IEA:Ensembl.
GO; GO:0045471; P:response to ethanol; IEA:Ensembl.
GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
InterPro; IPR017155; Hist-Lys_N-MeTrfase_SET.
InterPro; IPR003409; MORN.
InterPro; IPR001214; SET_dom.
Pfam; PF02493; MORN; 4.
Pfam; PF00856; SET; 1.
PIRSF; PIRSF037249; Histone_Lys_mtfrase_SET; 1.
SMART; SM00317; SET; 1.
PROSITE; PS51577; SAM_MT43_SET7; 1.
PROSITE; PS50280; SET; 1.
1: Evidence at protein level;
3D-structure; Activator; Chromatin regulator; Chromosome;
Complete proteome; Direct protein sequencing; Methyltransferase;
Nucleus; Reference proteome; Repeat; S-adenosyl-L-methionine;
Transcription; Transcription regulation; Transferase.
CHAIN 1 366 Histone-lysine N-methyltransferase SETD7.
/FTId=PRO_0000186054.
REPEAT 36 58 MORN 1.
REPEAT 59 81 MORN 2.
REPEAT 106 128 MORN 3.
DOMAIN 214 336 SET. {ECO:0000255|PROSITE-
ProRule:PRU00190}.
REGION 226 228 S-adenosyl-L-methionine binding.
REGION 256 258 Substrate binding.
REGION 266 268 Substrate binding.
REGION 296 297 S-adenosyl-L-methionine binding.
COMPBIAS 51 54 Poly-Phe.
BINDING 245 245 Substrate.
BINDING 317 317 Substrate.
BINDING 335 335 Substrate; via carbonyl oxygen.
BINDING 356 356 S-adenosyl-L-methionine; via carbonyl
oxygen. {ECO:0000255|PROSITE-
ProRule:PRU00190,
ECO:0000269|PubMed:12514135,
ECO:0000269|PubMed:12540855}.
MUTAGEN 220 220 E->A: Increases near-attack
conformations.
{ECO:0000269|PubMed:16433545}.
MUTAGEN 228 228 E->A: Increases near-attack
conformations.
{ECO:0000269|PubMed:16433545}.
MUTAGEN 245 245 Y->A: Significantly reduces the
monomethyltransferase activity but
increases the dimethyltransferase
activity. {ECO:0000269|PubMed:12540855,
ECO:0000269|PubMed:16433545}.
MUTAGEN 294 294 K->A: Significantly reduces the catalytic
activity. {ECO:0000269|PubMed:16433545}.
MUTAGEN 297 297 H->A,G: Abolishes methyltransferase
activity. {ECO:0000269|PubMed:11779497,
ECO:0000269|PubMed:11850410,
ECO:0000269|PubMed:15099517,
ECO:0000269|PubMed:15525938,
ECO:0000269|PubMed:16141209}.
MUTAGEN 317 317 K->A: Induces a reduction in
methyltransferase activity toward TAF10
but an increased methyltransferase
activity for H3 and p53/TP53.
{ECO:0000269|PubMed:16415881}.
STRAND 54 56 {ECO:0000244|PDB:1H3I}.
STRAND 61 64 {ECO:0000244|PDB:1H3I}.
STRAND 67 75 {ECO:0000244|PDB:1H3I}.
STRAND 81 87 {ECO:0000244|PDB:1H3I}.
STRAND 90 98 {ECO:0000244|PDB:1H3I}.
STRAND 100 102 {ECO:0000244|PDB:1H3I}.
STRAND 104 111 {ECO:0000244|PDB:1H3I}.
HELIX 114 116 {ECO:0000244|PDB:3M58}.
STRAND 119 122 {ECO:0000244|PDB:2F69}.
STRAND 128 131 {ECO:0000244|PDB:2F69}.
STRAND 135 137 {ECO:0000244|PDB:4J83}.
STRAND 141 147 {ECO:0000244|PDB:2F69}.
STRAND 151 160 {ECO:0000244|PDB:2F69}.
STRAND 163 176 {ECO:0000244|PDB:2F69}.
STRAND 179 184 {ECO:0000244|PDB:2F69}.
STRAND 186 188 {ECO:0000244|PDB:1MT6}.
TURN 203 206 {ECO:0000244|PDB:3M57}.
HELIX 210 213 {ECO:0000244|PDB:2F69}.
STRAND 216 220 {ECO:0000244|PDB:2F69}.
TURN 224 226 {ECO:0000244|PDB:1MUF}.
STRAND 228 234 {ECO:0000244|PDB:2F69}.
STRAND 241 245 {ECO:0000244|PDB:2F69}.
STRAND 248 250 {ECO:0000244|PDB:2F69}.
HELIX 252 256 {ECO:0000244|PDB:2F69}.
HELIX 260 262 {ECO:0000244|PDB:2F69}.
STRAND 266 268 {ECO:0000244|PDB:1H3I}.
STRAND 270 272 {ECO:0000244|PDB:2F69}.
STRAND 274 276 {ECO:0000244|PDB:2F69}.
TURN 279 282 {ECO:0000244|PDB:2F69}.
TURN 284 286 {ECO:0000244|PDB:2F69}.
HELIX 292 294 {ECO:0000244|PDB:2F69}.
STRAND 295 300 {ECO:0000244|PDB:1H3I}.
STRAND 302 310 {ECO:0000244|PDB:2F69}.
TURN 311 313 {ECO:0000244|PDB:2F69}.
STRAND 314 323 {ECO:0000244|PDB:2F69}.
STRAND 330 333 {ECO:0000244|PDB:2F69}.
STRAND 338 340 {ECO:0000244|PDB:1O9S}.
STRAND 344 346 {ECO:0000244|PDB:3OS5}.
HELIX 351 363 {ECO:0000244|PDB:2F69}.
SEQUENCE 366 AA; 40721 MW; 73A1217079E3BA13 CRC64;
MDSDDEMVEE AVEGHLDDDG LPHGFCTVTY SSTDRFEGNF VHGEKNGRGK FFFFDGSTLE
GYYVDDALQG QGVYTYEDGG VLQGTYVDGE LNGPAQEYDT DGRLIFKGQY KDNIRHGVCW
IYYPDGGSLV GEVNEDGEMT GEKIAYVYPD ERTALYGKFI DGEMIEGKLA TLMSTEEGRP
HFELMPGNSV YHFDKSTSSC ISTNALLPDP YESERVYVAE SLISSAGEGL FSKVAVGPNT
VMSFYNGVRI THQEVDSRDW ALNGNTLSLD EETVIDVPEP YNHVSKYCAS LGHKANHSFT
PNCIYDMFVH PRFGPIKCIR TLRAVEADEE LTVAYGYDHS PPGKSGPEAP EWYQVELKAF
QATQQK
Related products :
GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45
Fax 0032 16 50 90 45
info@gentaur.com | Gentaur
GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur
GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50
Fax 01 43 25 01 60
RCS Paris B 484 237 888
SIRET 48423788800017
BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG
france@gentaur.com | Gentaur
GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88
Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur
GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com
Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123
GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel: 0208-080893 Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62 SWIFT RABONL2U
GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur
ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF
GENTAUR Poland Sp. z o.o.
ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX 058 710 33 48
poland@gentaur.com | Gentaur
Other countries
Österreich +43720880899
Canada Montreal +15149077481
Ceská republika Praha +420246019719
Danmark +4569918806
Finland Helsset +358942419041
Magyarország Budapest +3619980547
Ireland Dublin+35316526556
Luxembourg+35220880274
Norge Oslo+4721031366
Sverige Stockholm+46852503438
Schweiz Züri+41435006251
US New York+17185132983
GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo
Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur
Pathways :
WP1673: Naphthalene and anthracene degradation
WP1700: Selenoamino acid metabolism
WP1714: Tyrosine metabolism
WP1006: metapathway biotransformation
WP1124: metapathway biotransformation
WP1212: metapathway biotransformation
WP1251: metapathway biotransformation
WP1286: metapathway biotransformation
WP1581: Histidine metabolism
WP702: metapathway biotransformation
WP889: metapathway biotransformation
WP1669: Lysine biosynthesis
WP1689: Porphyrin and chlorophyll metabolism
WP2361: Gastric cancer network 1
WP2366: Butyrate-induced histone acetylation
WP2369: Histone modifications
WP300: Histone modifications
WP533: Lysine Biosynthesis
WP1049: G Protein Signaling Pathways
WP1165: G Protein Signaling Pathways
WP1371: G Protein Signaling Pathways
WP1438: Influenza A virus infection
WP1493: Carbon assimilation C4 pathway
WP1502: Mitochondrial biogenesis
WP1531: Vitamin D synthesis
Related Genes :
[EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D] Histone-lysine N-methyltransferase EHMT1 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 1) (Eu-HMTase1) (G9a-like protein 1) (GLP) (GLP1) (Histone H3-K9 methyltransferase 5) (H3-K9-HMTase 5) (Lysine N-methyltransferase 1D)
[EHMT2 BAT8 C6orf30 G9A KMT1C NG36] Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a)
[Ehmt2 Bat8 G9a Ng36] Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a)
[Ehmt1 Euhmtase1 Glp Kmt1d] Histone-lysine N-methyltransferase EHMT1 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 1) (Eu-HMTase1) (G9a-like protein 1) (GLP) (GLP1) (Lysine N-methyltransferase 1D)
[DOT1 KMT4 PCH1 YDR440W D9461.26] Histone-lysine N-methyltransferase, H3 lysine-79 specific (EC 2.1.1.43) (Disrupter of telomere silencing protein 1) (Histone H3-K79 methyltransferase) (H3-K79-HMTase) (Lysine N-methyltransferase 4)
[DOT1L KIAA1814 KMT4] Histone-lysine N-methyltransferase, H3 lysine-79 specific (EC 2.1.1.43) (DOT1-like protein) (Histone H3-K79 methyltransferase) (H3-K79-HMTase) (Lysine N-methyltransferase 4)
[clr4 kmt1 SPBC428.08c] Histone-lysine N-methyltransferase, H3 lysine-9 specific (EC 2.1.1.43) (Cryptic loci regulator 4) (Histone H3-K9 methyltransferase) (H3-K9-HMTase) (Lysine N-methyltransferase 1)
[SETDB1 KIAA0067 KMT1E] Histone-lysine N-methyltransferase SETDB1 (EC 2.1.1.43) (ERG-associated protein with SET domain) (ESET) (Histone H3-K9 methyltransferase 4) (H3-K9-HMTase 4) (Lysine N-methyltransferase 1E) (SET domain bifurcated 1)
[SETD7 KIAA1717 KMT7 SET7 SET9] Histone-lysine N-methyltransferase SETD7 (EC 2.1.1.43) (Histone H3-K4 methyltransferase SETD7) (H3-K4-HMTase SETD7) (Lysine N-methyltransferase 7) (SET domain-containing protein 7) (SET7/9)
[SUV39H1 KMT1A SUV39H] Histone-lysine N-methyltransferase SUV39H1 (EC 2.1.1.43) (Histone H3-K9 methyltransferase 1) (H3-K9-HMTase 1) (Lysine N-methyltransferase 1A) (Position-effect variegation 3-9 homolog) (Suppressor of variegation 3-9 homolog 1) (Su(var)3-9 homolog 1)
[KMT5A PRSET7 SET07 SET8 SETD8] N-lysine methyltransferase KMT5A (EC 2.1.1.-) (H4-K20-HMTase KMT5A) (Histone-lysine N-methyltransferase KMT5A) (EC 2.1.1.43) (Lysine N-methyltransferase 5A) (Lysine-specific methylase 5A) (PR/SET domain-containing protein 07) (PR-Set7) (PR/SET07) (SET domain-containing protein 8)
[SUVH4 KYP SDG33 SET33 At5g13960 MAC12.7] Histone-lysine N-methyltransferase, H3 lysine-9 specific SUVH4 (EC 2.1.1.43) (Histone H3-K9 methyltransferase 4) (H3-K9-HMTase 4) (Protein KRYPTONITE) (Protein SET DOMAIN GROUP 33) (Suppressor of variegation 3-9 homolog protein 4) (Su(var)3-9 homolog protein 4)
[SETMAR] Histone-lysine N-methyltransferase SETMAR (SET domain and mariner transposase fusion protein) (Metnase) [Includes: Histone-lysine N-methyltransferase (EC 2.1.1.43); Transposon Hsmar1 transposase (EC 3.1.-.-)]
[dim-5 29E8.110 NCU04402] Histone-lysine N-methyltransferase, H3 lysine-9 specific dim-5 (EC 2.1.1.43) (Histone H3-K9 methyltransferase dim-5) (H3-K9-HMTase dim-5) (HKMT)
[gpp CG10272] Histone-lysine N-methyltransferase, H3 lysine-79 specific (EC 2.1.1.43) (DOT1-like protein) (dDOT1L) (Histone H3-K79 methyltransferase) (H3-K79-HMTase) (Protein grappa)
[SUV39H2 KMT1B] Histone-lysine N-methyltransferase SUV39H2 (EC 2.1.1.43) (Histone H3-K9 methyltransferase 2) (H3-K9-HMTase 2) (Lysine N-methyltransferase 1B) (Suppressor of variegation 3-9 homolog 2) (Su(var)3-9 homolog 2)
[KDM2A CXXC8 FBL7 FBXL11 JHDM1A KIAA1004] Lysine-specific demethylase 2A (EC 1.14.11.27) (CXXC-type zinc finger protein 8) (F-box and leucine-rich repeat protein 11) (F-box protein FBL7) (F-box protein Lilina) (F-box/LRR-repeat protein 11) (JmjC domain-containing histone demethylation protein 1A) ([Histone-H3]-lysine-36 demethylase 1A)
[NSD1 ARA267 KMT3B] Histone-lysine N-methyltransferase, H3 lysine-36 and H4 lysine-20 specific (EC 2.1.1.43) (Androgen receptor coactivator 267 kDa protein) (Androgen receptor-associated protein of 267 kDa) (H3-K36-HMTase) (H4-K20-HMTase) (Lysine N-methyltransferase 3B) (Nuclear receptor-binding SET domain-containing protein 1) (NR-binding SET domain-containing protein)
[SETD1A KIAA0339 KMT2F SET1 SET1A] Histone-lysine N-methyltransferase SETD1A (EC 2.1.1.43) (Lysine N-methyltransferase 2F) (SET domain-containing protein 1A) (hSET1A) (Set1/Ash2 histone methyltransferase complex subunit SET1)
[Su(var)3-9 KMT1 CG6476] Histone-lysine N-methyltransferase Su(var)3-9 (EC 2.1.1.43) (Histone H3-K9 methyltransferase) (H3-K9-HMTase) (Lysine N-methyltransferase 1) (Protein suppressor of variegation 3-9)
[KDM2B CXXC2 FBL10 FBXL10 JHDM1B PCCX2] Lysine-specific demethylase 2B (EC 1.14.11.27) (CXXC-type zinc finger protein 2) (F-box and leucine-rich repeat protein 10) (F-box protein FBL10) (F-box/LRR-repeat protein 10) (JmjC domain-containing histone demethylation protein 1B) (Jumonji domain-containing EMSY-interactor methyltransferase motif protein) (Protein JEMMA) (Protein-containing CXXC domain 2) ([Histone-H3]-lysine-36 demethylase 1B)
[Kdm2b Fbl10 Fbxl10 Jhdm1b Kiaa3014] Lysine-specific demethylase 2B (EC 1.14.11.27) (F-box and leucine-rich repeat protein 10) (F-box protein FBL10) (F-box/LRR-repeat protein 10) (JmjC domain-containing histone demethylation protein 1B) ([Histone-H3]-lysine-36 demethylase 1B)
[SETD2 HIF1 HYPB KIAA1732 KMT3A SET2 HSPC069] Histone-lysine N-methyltransferase SETD2 (EC 2.1.1.43) (HIF-1) (Huntingtin yeast partner B) (Huntingtin-interacting protein 1) (HIP-1) (Huntingtin-interacting protein B) (Lysine N-methyltransferase 3A) (Protein-lysine N-methyltransferase SETD2) (EC 2.1.1.-) (SET domain-containing protein 2) (hSET2) (p231HBP)
[Kdm2a Fbxl11 Jhdm1a Kiaa1004] Lysine-specific demethylase 2A (EC 1.14.11.27) (F-box and leucine-rich repeat protein 11) (F-box/LRR-repeat protein 11) (JmjC domain-containing histone demethylation protein 1A) ([Histone-H3]-lysine-36 demethylase 1A)
[KAT2A GCN5 GCN5L2] Histone acetyltransferase KAT2A (EC 2.3.1.48) (General control of amino acid synthesis protein 5-like 2) (Histone acetyltransferase GCN5) (hGCN5) (Histone succinyltransferase KAT2A) (EC 2.3.1.-) (Lysine acetyltransferase 2A) (STAF97)
[SET1 KMT2 YTX1 YHR119W] Histone-lysine N-methyltransferase, H3 lysine-4 specific (EC 2.1.1.43) (COMPASS component SET1) (Lysine N-methyltransferase 2) (SET domain-containing protein 1)
[Setd2 Kiaa1732 Kmt3a] Histone-lysine N-methyltransferase SETD2 (EC 2.1.1.43) (Lysine N-methyltransferase 3A) (Protein-lysine N-methyltransferase SETD2) (EC 2.1.1.-) (SET domain-containing protein 2)
[KAT2B PCAF] Histone acetyltransferase KAT2B (EC 2.3.1.48) (Histone acetyltransferase PCAF) (Histone acetylase PCAF) (Lysine acetyltransferase 2B) (P300/CBP-associated factor) (P/CAF)
[Kat2a Gcn5l2] Histone acetyltransferase KAT2A (EC 2.3.1.48) (General control of amino acid synthesis protein 5-like 2) (Histone acetyltransferase GCN5) (MmGCN5) (Histone succinyltransferase KAT2A) (EC 2.3.1.-) (Lysine acetyltransferase 2A)
[Kdm2 Jhd1 CG11033] JmjC domain-containing histone demethylation protein 1 (EC 1.14.11.27) (Lysine (K)-specific demethylase 2) ([Histone-H3]-lysine-36 demethylase 1)
Bibliography :
No related Items
Enter catalog number :
Favorites Pages:
No Favorits